Company Structure

Trustlife Global, headquartered in the US, operates through a robust international infrastructure with specialized centers across Europe. The Core Technology Team at Trustlife Therapeutics in London, UK, is at the forefront of AI asset development, bringing together highly qualified technical experts, including software developers, systems biologists and scientific advisors. Meanwhile, the Trustlife Labs Drug R&D Center in Istanbul, Turkey, focuses on advancing lab assets through preclinical research, lab validation, and experimental prototyping. Complementing these efforts, ScandiEdge Therapeutics AB in Stockholm, Sweden, drives small molecule development, particularly targeting MASLD and liver cancer.

This strategic distribution of expertise and resources ensures a comprehensive and innovative approach to drug discovery on a global scale.